Delivery Order SPE2DB24D1034-SPE2DB24FWCJ2

Award Date 9/6/24
Potential Completion Date 9/27/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ENVARSUS XR 1 MG TABLET 30S. The contract has a ceiling value of $2,168.68 and a period of performance through July 2, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,288.86. The contract has an ultimate completion date of June 9, 2025 and was awarded on May 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract has a ceiling value of $3,436.96 and is a firm fixed price, non-set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,035.60 and a period of performance through July 10, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $2,577.72, and a period of performance ending on June 10, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 30S, a pharmaceutical product, with a total ceiling value of $3,106.80 and a period of performance through June 6, 2025. The contract is a firm fixed-price delivery order, and is not set aside for any specific business category. AmerisourceBergen...
This is a $1,718.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a period of performance through May 5, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract has a firm fixed price, with a ceiling value of $1,711.95 and a period of performance through July 7, 2025. This delivery order is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $3,423.90 and a performance period through July 1, 2025. The contract is a firm fixed-price, non-set-aside vehicle. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,589.00, is for the supply of ENVARSUS XR 1 MG TABLET 30S, a specialty medication. The contract has a period of performance through February 13, 2025 and utilizes a Firm Fixed Price pricing type. This delivery order is issued under a larger Indefinite Delivery...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB24FWCJ2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENVARSUS XR 1 MG TABLET 30S. The contract has a ceiling value of $1,465.68 and is a firm-fixed price contract with a period of performance through September 27, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as a primary vehicle for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.

Generated 12/6/24, 9:21 AM